Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0030567 (
Parkinson's disease
)
63,064
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Phosphoglycerate dehydrogenase
(
PHGDH
) catalyzes the first step in the synthesis of the amino acid serine, important for protein synthesis, one-carbon metabolism, lipid production, redox homeostasis, and other key processes of normal and cancer metabolism. While
PHGDH
is often overexpressed in cancer cells, how it is regulated has been unclear. In this issue of the JCI, Liu and colleagues describe a new aspect of
PHGDH
regulation, demonstrating that the
Parkinson disease
gene and tumor suppressor Parkin bound and ubiquitinated
PHGDH
. Parkin promoted
PHGDH
degradation, suppressed serine synthesis, and inhibited tumor growth in human cancer cell line xenografts. Conversely, inactivation of Parkin not only accelerated tumor growth, but also sensitized tumors to small molecule inhibitors of
PHGDH
. These results offer a new link between Parkin and the serine synthesis pathway, and they bear translational potential that warrants further study in Parkin-deficient human cancers.
...
PMID:Parkin on serine: a Parkinson disease gene suppresses serine synthesis in cancer. 3242 Sep 15
Phosphoglycerate dehydrogenase
(
PHGDH
), the first rate-limiting enzyme of serine synthesis, is frequently overexpressed in human cancer.
PHGDH
overexpression activates serine synthesis to promote cancer progression. Currently,
PHGDH
regulation in normal cells and cancer is not well understood. Parkin, an E3 ubiquitin ligase involved in
Parkinson's disease
, is a tumor suppressor. Parkin expression is frequently downregulated in many types of cancer, and its tumor-suppressive mechanism is poorly defined. Here, we show that
PHGDH
is a substrate for Parkin-mediated ubiquitination and degradation. Parkin interacted with
PHGDH
and ubiquitinated
PHGDH
at lysine 330, leading to
PHGDH
degradation to suppress serine synthesis. Parkin deficiency in cancer cells stabilized
PHGDH
and activated serine synthesis to promote cell proliferation and tumorigenesis, which was largely abolished by targeting
PHGDH
with RNA interference, CRISPR/Cas9 KO, or small-molecule
PHGDH
inhibitors. Furthermore, Parkin expression was inversely correlated with
PHGDH
expression in human breast cancer and lung cancer. Our results revealed
PHGDH
ubiquitination by Parkin as a crucial mechanism for
PHGDH
regulation that contributes to the tumor-suppressive function of Parkin and identified Parkin downregulation as a critical mechanism underlying
PHGDH
overexpression in cancer.
...
PMID:Parkin ubiquitinates phosphoglycerate dehydrogenase to suppress serine synthesis and tumor progression. 3247 81